Genmab
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell Genmab and other ETFs, options, and stocks.About GMAB
Genmab A/S is an international biotechnology company, which engages in the development of human antibody therapeutics for the treatment of cancer and other diseases. Its product pipeline includes daratumumab, marketed as DARZALEX for the treatment of certain indications of multiple myeloma, teprotumumab-trbw marketed as TEPEZZA for the treatment of thyroid eye disease, and ofatumumab, marketed as Arzerra for the treatment of certain indications of chronic lymphocytic leukemia.
CEOJan G. J. van de Winkel
CEOJan G. J. van de Winkel
Employees3,029
Employees3,029
HeadquartersCopenhagen, Central Denmark
HeadquartersCopenhagen, Central Denmark
Founded1998
Founded1998
Employees3,029
Employees3,029
GMAB Key Statistics
Market cap31.95B
Market cap31.95B
Price-Earnings ratio43.62
Price-Earnings ratio43.62
Dividend yield—
Dividend yield—
Average volume4.55M
Average volume4.55M
High today$52.82
High today$52.82
Low today$51.51
Low today$51.51
Open price$52.65
Open price$52.65
Volume2.41M
Volume2.41M
52 Week high$59.97
52 Week high$59.97
52 Week low$23.62
52 Week low$23.62
GMAB News
Simply Wall St 2d
We Think You Can Look Beyond Genmab's Lackluster Earnings - Simply Wall St...
TipRanks 4d
Genmab Reports Share Sales by Two Board MembersGenmab ( (GMAB) ) has provided an update. On November 12, 2026, Genmab reported that board members Martin Schultz and Mijke Zachariasse sold 617 and 351 Genmab...
TipRanks 4d
Genmab Files Articles of Association Dated November 10Genmab ( (GMAB) ) has shared an announcement. Genmab A/S is engaged in medical research, production and sale of related products, and related business. Its Art...
Analyst ratings
81%
of 26 ratingsBuy
80.8%
Hold
11.5%
Sell
7.7%
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.